GPCR vs CPRX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: May 16, 2026

GPCR

56.1
AI Score
VS
CPRX Wins

CPRX

60.2
AI Score

Investment Advisor Scores

GPCR

56score
Recommendation
HOLD

CPRX

60score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric GPCR CPRX Winner
Net Income -75.97M 214.33M CPRX
Operating Income -89.38M 257.78M CPRX
ROE -5.2% 22.5% CPRX
ROA -5.0% 19.4% CPRX
Total Assets 1.51B 1.10B GPCR
Cash 316.17M 709.17M CPRX
Current Ratio 26.16 6.08 GPCR
Free Cash Flow 14.05M 208.61M CPRX

Relative Price Performance (Last 90 Days)

GPCR 1M: -28.3% · 3M: -10.7% CPRX 1M: +0.4% · 3M: +24.3%

Current Technical Phase

GPCR

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 26

RSI (14): 26.4 · Price: $38.66

CPRX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.9% over 20 days), RSI 71

RSI (14): 70.7 · Price: $31.49

Fundamentals Snapshot

Metric GPCR CPRX
Market Cap
Forward P/E -17.8 9.9
Trailing P/E 18.2
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.8%
Operating Margin 0.0% 0.5%
EPS -2.91 1.73
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, CPRX is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.